Also listed on Pharmedium Services, LLC, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jan 17, 2033 · Medium confidence
20-year base term ends Jan 17, 2033
Why Medium: A parent in the chain could not be resolved.
Held by Hikma Pharmaceuticals USA Inc.
Filed Dec 2, 2013 as application 14/093,765 · Granted Aug 19, 2014
Base term, 20 years from filing
Today
2013
2033
Clock starts
Jan 17, 2013
Jan 17, 2013
Term ends
Jan 17, 2033
Jan 17, 2033
Granted
Aug 19, 2014
Aug 19, 2014
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 17, 2013, when application 13/743,981, the earliest non-provisional in its chain, was filed (this one was filed Dec 2, 2013); a parent in its chain could not be resolved (the next row) | Jan 17, 2033 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 17, 2033 | Medium confidence |
This family
| Application 13/743,981 | Abandoned not computed | not computed |
| US 8,597,271 | In force Jan 2033 | Jan 2033 |
| US 8,808,249 | this patent Jan 2033 | Jan 2033 |
| US 9,579,254 | In force Jan 2033 | Jan 2033 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 20, 2014 Reel 32301, frame 828 | Pharmedium Services, LLC | Jpmorgan Chase Bank, N.a. | Notice and Confirmation of Grant of Security Interest in Patents-First Lien |
| Feb 20, 2014 Reel 32302, frame 275 | Pharmedium Services, LLC | Credit Suisse AG | Notice and Confirmation of Grant of Security Interest in Patents - Second Lien |
| Nov 11, 2015 Reel 37097, frame 493 | Credit Suisse AG | Pharmedium Services, LLC | Termination and Release of Security Interest in Patent Rights - Second Lien |
| Nov 11, 2015 Reel 37097, frame 514 | Jpmorgan Chase Bank, N.a. | Pharmedium Services, LLC | Termination and Release of Security Interest in Patent Rights - First Lien |
| Aug 31, 2020 Reel 53646, frame 281 | Pharmedium Service, LLC | Runway Advisors, LLC | Assignment of Assignor's Interest |
| Feb 16, 2021 Reel 55270, frame 335 | Runway Advisors, LLC | Hikma Pharmaceuticals USA Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Jan 2033
Term ends Jan 17, 2033. No further fees fall due before then
Citations
9
later US patents cite this one
That is above the median of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.